"Cellenkos gains FDA orphan drug status for CK0804 to treat myelofibrosis" was originally created and published by ...

Treg therapeutic designed to preferentially traffic towards its ligand CXCL12 over expressed in the bone marrow and spleen in myelofibrosis. -- CK0804 engages with antigen presenting cells within ...

Scientists say special immune cells in the body can damage bone marrow over the years and contribute to leukaemia, a ...

Inflammation covertly rewires the bone marrow, enabling mutated stem cells to rise and setting the stage for future blood disease.

And the discovery could soon lead to personalized treatments for children with leukemia and bone marrow failure disorders. The research, led by Murdoch Children's Research Institute (MCRI) and ...

Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that ...

The study shows that fat tissue, when processed and cultured in a specific way, can self-organize into structures resembling ...

The term “rare blood disorders” describes less common conditions that affect blood cells’ ability to function correctly. Myeloproliferative disorders and lymphoproliferative disorders are two types of ...

A bone marrow biopsy is a medical procedure used to collect a small sample of bone marrow, which is the soft, spongy tissue inside your bones where blood cells are made. This test helps a physician ...

PARIS (Reuters) - Sanofi has halted all clinical trials and cancelled plans to seek regulatory approval of fedratinib, a drug in late-stage development against rare bone marrow cancers, due to safety ...